ArticlePharmaceuticals (Basel, Switzerland)2026
Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study.
Cody O'Rear et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.